89 related articles for article (PubMed ID: 17970757)
1. How to identify patients with vulnerable plaques.
Virani SS; Ballantyne CM
Diabetes Obes Metab; 2008 Sep; 10(10):824-33. PubMed ID: 17970757
[TBL] [Abstract][Full Text] [Related]
2. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
3. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.
Cola C; Clementi E; Biondi-Zoccai G; Sangiorgi G
Acta Chir Belg; 2007; 107(2):129-42. PubMed ID: 17515260
[TBL] [Abstract][Full Text] [Related]
4. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.
Horinaka S; Yabe A; Yagi H; Ishimura K; Hara H; Iemua T; Matsuoka H
Angiology; 2009; 60(4):468-76. PubMed ID: 19015165
[TBL] [Abstract][Full Text] [Related]
5. How to identify the asymptomatic high-risk patient?
Schuijf JD; Achenbach S; Zoghbi WA; Boersma E; Raggi P; Weber M; Nagel E; Narula J; Wackers FJ; Poldermans D; Bax JJ
Curr Probl Cardiol; 2009 Nov; 34(11):539-77. PubMed ID: 19804855
[TBL] [Abstract][Full Text] [Related]
6. Identifying the vulnerable patient with rupture-prone plaque.
Weintraub HS
Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
[TBL] [Abstract][Full Text] [Related]
7. The vulnerable patient: refocusing on the plaque?
Eijgelaar WJ; Heeneman S; Daemen MJ
Thromb Haemost; 2009 Aug; 102(2):231-9. PubMed ID: 19652873
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
Anderson JL
Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
[TBL] [Abstract][Full Text] [Related]
9. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
10. Extracoronary atherosclerosis in patients with chronic ischemic heart disease: relationship with risk factors and the severity of coronary artery disease.
Pipitone S; Corrado E; Muratori I; Novo G; Evola S; Fabbiano A; Trapani R; Zarcone P; Assennato P; Hoffmann E; Novo S
Int Angiol; 2007 Dec; 26(4):346-52. PubMed ID: 18091702
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-associated phospholipase A2: an independent predictor of cardiovascular risk and a novel target for immunomodulation therapy.
Khakpour H; Frishman WH
Cardiol Rev; 2009; 17(5):222-9. PubMed ID: 19690473
[TBL] [Abstract][Full Text] [Related]
12. Non-conventional markers of atherosclerosis before and after gastric banding surgery.
Hanusch-Enserer U; Zorn G; Wojta J; Kopp CW; Prager R; Koenig W; Schillinger M; Roden M; Huber K
Eur Heart J; 2009 Jun; 30(12):1516-24. PubMed ID: 19380349
[TBL] [Abstract][Full Text] [Related]
13. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of premature atherosclerosis.
Kampoli AM; Tousoulis D; Antoniades C; Siasos G; Stefanadis C
Trends Mol Med; 2009 Jul; 15(7):323-32. PubMed ID: 19577961
[TBL] [Abstract][Full Text] [Related]
15. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ankle-brachial index and carotid intima-media thickness in HIV-infected patients.
Gutiérrez F; Bernal E; Padilla S; Hernández I; Masiá M
AIDS; 2008 Jul; 22(11):1369-71. PubMed ID: 18580617
[TBL] [Abstract][Full Text] [Related]
18. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
Koenig W
Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
[TBL] [Abstract][Full Text] [Related]
19. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein-associated phospholipase A2 and risk of stroke.
Gorelick PB
Am J Cardiol; 2008 Jun; 101(12A):34F-40F. PubMed ID: 18549870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
